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Background: There is no national policy for allocation of kidneys from Donation after circulatory death (DCD)
donors in the UK. Allocation is geographical and based on individual/regional centre policies. We have
evaluated the short term outcomes of paired kidneys from DCD donors subject to this allocation policy.
Methods: Retrospective analysis of paired renal transplants from DCD’s from 2002 to 2010 in London. Cold
ischemia time (CIT), recipient risk factors, delayed graft function (DGF), 3 and 12 month creatinine)
were compared.
Results: Complete data was available on 129 paired kidneys.115 pairs were transplanted in the same centre
and 14 pairs transplanted in different centres. There was a significant increase in CIT in kidneys transplanted
second when both kidneys were accepted by the same centre (15.5 ± 4.1 vs 20.5 ± 5.8 hrs p < 0.0001 and at
different centres (15.8 ± 5.3 vs. 25.2 ± 5.5 hrs p = 0.0008). DGF rates were increased in the second implant
following sequential transplantation (p = 0.05).
Conclusions: Paired study sequential transplantation of kidneys from DCD donors results in a significant
increase in CIT for the second kidney, with an increased risk of DGF. Sequential transplantation from a DCD
donor should be avoided either by the availability of resources to undertake simultaneous procedures or the
allocation of kidneys to 2 separate centres.
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In the United Kingdom (UK) kidneys from brain-dead
donors (DBD) are allocated through a national organ
sharing scheme that matches the donor to the best re-
cipient.The UK Kidney Allocation Scheme introduced in
April 2006 prioritises patients with ideal tissue matches
(000 HLA mismatches) and blood group matching, then
assigns points to patients based on the level of tissue
match between donor and recipient, the length of time* Correspondence: shanka.benaragama@nhs.net
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article, unless otherwise stated.spent waiting for a transplant, age of the recipient (with
a progressive reduction in points given after the age of
thirty) and location points such that patients geographic-
ally close to the retrieval centre receive more points.
The patients with the highest number of points for a do-
nated kidney are preferentially offered the kidney, no
matter where in the UK they receive their treatment.
In contrast, there is no standardized policy for alloca-
tion of kidneys retrieved from donors after circulatory
death (DCD). Allocation is often based on regional and
individual centre policy. The current practice in the Pan
Thames region encompassing 5 units which serve the
Greater London area and South Eastern England is a
center based allocation wherein, a single centre is initiallyntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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centre usually transplants both kidneys although at times
one kidney may be subsequently re-allocated to another
centre. The implications of this allocation policy in terms
of graft outcome have not been previously evaluated.
Whilst long term outcomes and graft survival are similar
between DBDs and DCDs, it has been well established that
kidneys from DCD’s have higher rates of primary non-
function (PNF) and delayed graft function (DGF) than from
DBD kidneys [1-4]. These differences impact on in-hospital
stay and overall costs which are consequently much higher
in DCD compared to DBD transplants. Primary warm is-
chemia time (WIT) and haemodynamic events around the
retrieval period are likely to be responsible for the increase
in DGF/PNF in DCD kidneys and is accepted as an inevit-
able consequence of use of this donor source [5]. DCD or-
gans are being increasingly utilized due to the shortage of
DBD kidneys and the ever expanding number of patients
requiring a transplant. In the UK the use of kidneys from
DCD donors has risen from 3% of all deceased donors in
2000 to 82% in 2012. Between April 2011 and March 2012,
674 kidney transplants from donors after circulatory death
(17% increase compared with the previous year) took place
and accounted for one in four of all kidney transplants [6].
Hence, it is important to identify and overcome factors
which may adversely affect the outcome of DCD kidney
transplants both in terms of patient interest and health care
economics.
In addition to warm ischaemic damage, cold ischemia
time (CIT), donor age, recipient body mass index and pre-
transplant dialysis are factors contributing to the risk of
DGF [7-9]. Of these, CIT is probably the most readily
modifiable factor for both DBD and DCD transplantation
[10-12]. Minimizing CIT reduces not only DGF but also
acute rejection episodes and graft loss which are both in-
creased in cases of DGF [11].
When both kidneys from a single donor are allocated
to the same centre which has been the standard practice
in our region, the recipient operations are most likely to
occur sequentially rather than simultaneously due to staff
and operating theatre availability. An inevitable anticipated
consequence of this practice is a substantial difference in
cold ischemia times between the two recipients which then
could potentially impact on graft outcomes. Conversely, if
kidneys from a given donor are sent to different centres’ in
close proximity, then similar CIT’s for both organs should
be the anticipated outcome.
In this audit we compared the outcomes between paired
DCD kidneys within our regional allocation policy of both
kidneys being offered to a single centre. Our aim was
to determine whether this policy resulted in clinically
significant delays in the implantation of the second kidney
with the increased CIT impacting on DGF and patient
outcome.Methods
Prospectively collected data on all adult recipients who
had renal transplants from DCD’s within the Pan Thames
region from April 2002 to March 2010 was reviewed. The
Pan Thames region comprises five London transplant
centres (Royal Free, Guy’s, West London, Royal London
and St George’s) that provide renal transplantation to
the Greater London and South Eastern England serving
a population of approximately 12 million.
For the purposes of the audit we defined ‘simultaneous
transplants’ as those occurring when there was <3 hours
difference in CIT as this time difference is only feasible
with access to 2 theatres. ‘Sequential transplants’ were de-
fined as those with ≥3 hours difference in CIT between
the two grafts. PNF was defined as a graft that never
achieved sufficient function to allow discontinuation of
dialysis and DGF as the need for dialysis in the first week
after transplantation.
Donor details and recipient centres were identified
from United Kingdom Transplant (UKT) registry. Recipi-
ent demographics, comorbidities, secondary warm ischae-
mic time, PNF, DGF, serum creatinine at three months
and twelve months were retrieved from hospital records.
Retrieval biopsies on donor kidneys are not performed
routinely to evaluate the donors in the Pan Thames area.
HLA-mismatching was not recorded in patient case notes.
Exclusion criteria included; un-linked data between
the donor and recipient, missing data, kidneys exported
outside the Pan Thames region and multi-organ trans-
plantation (usually kidney-pancreas). All patients active
on UK transplant list gave informed consent for data
collection and analysis by UKT. Our audit was approved
by the PanThames audit committee which has links to
the PanThames health care commissioners. All chief ex-
ecutives of the hospitals involved in the audit were con-
tacted and approval sought prior to the audit. This audit
was conducted in accordance with the guidelines set out
by the UK Department of Health.
Statistical analysis
Analysis was done using STATVIEW (SAS Institute Inc.,
Cary, NC). Descriptive statistics was used to present demo-
graphic, transplant and outcome related data. Categorical
variables were compared using Chi-square and Fisher’s
exact test and continuous variables using unpaired‘t’ and
Mann–Whitney ‘U’ test,. Logistic regression analysis was
used to evaluate the impact of the order of implantation
on DGF. Data is displayed as mean ± standard deviation,
unless otherwise stipulated. Statistical significance was
taken at the p < 0.05 level.
Results
There were 326 DCD transplants during the study period.
PNF occurred in 5 patients. A total of 63 donors were
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outside the region (15), or because incomplete data (48).
Complete data was available on 129 paired kidneys. Both
kidneys from each donor were initially offered to one of
the 5 centres. A total of 115 pairs of kidneys were trans-
planted with both recipients at a single centre. In the
case of the remaining 14 donors representing 11% of the
total the kidneys were transplanted in 2 separate centres
(Table 1).
The demographics of the first and second recipients
are shown in Table 2. These groups were comparable
except for a higher proportion of patients on peritoneal
dialysis in the first recipients.
Cold ischaemia times
Paired kidneys same centre transplant
In cases where both kidneys from the same donor were
transplanted in a single centre there was a significant in-
crease in CIT for the second kidney (15.5 ± 4.1 vs. 20.5 ±
5.8 hrs p < 0.0001). This represented a mean and median
difference in CIT between paired kidneys of 4.9 ± 3.2 hours
(±SD) and 4.0 hours respectively (IQR 3) (Table 3). The
secondary WIT was also significantly shorter in the kidneys
transplanted second although complete data was available
only in 85 paired kidneys (38.0 ± 13.8 vs. 34.1 ± 11.8 mi-
nutes p = 0.047) (Table 2).
Paired kidneys different centre transplant
The CIT in kidneys transplanted second was also signifi-
cantly increased when the kidneys were used by different
centres (15.8 ± 5.3 vs. 25.2 ± 5.5 hours p = 0.0008) with
the mean and median difference in CIT between kidneys
of 9.5 ± 6.5 hrs (±SD) and 9.0 hrs respectively (Table 3).
Review of patient details for these transplants indi-
cated that this delay related to unsuitability of a planned
recipient at the first centre due to either a positive cross
match or recipient medical issues resulting in secondary
reallocation. Delays consequent to this arose due to the
need for further organ transport, recipient identification,
and crossmatching at the second centre.
Second kidneys only–single versus different centre
The CIT of the second kidney was significantly longer
when this was transplanted at a second centre compared
to when both kidneys were used at the same centre
(20.5 ± 5.8 vs. 25.2 ± 5.5 hours, p = 0.01). The number ofTable 1 Allocation of paired kidneys from DCDs
Allocation Simultaneous implant-
CIT < 3 hrs (n in pairs)
Sequential implant-
CIT ≥3 hrs (n in pairs)
Single centre: n = 115 24(21%) 91(79%)
2 Centre: n = 14 3(21%) 11(79%)
Total: N = 129 27(21%) 102(79%)simultaneous transplants was identical with single centre
and 2 centre recipient operations comprising 21% (24/
115 and 3/14) for both scenarios.
Short-term graft function (Serum creatinine levels)
The mean serum creatinine levels at 3 months for the first
and second kidneys implanted with CIT of 3 hours differ-
ence from the same donor were 161.3 and 159.1 umol/l
respectively. At 12 months it was 174.0 and 154.0 umol/l.
However, it did not achieve statistical significance for the
transplants performed with more than 4 hours of CIT dif-
ference (p = 0.55).
Delayed graft function
A total of 157/258 kidneys had primary function and
101/258 developed DGF. The median length of stay for
the DGF group was 12 days. Regression analysis did not
show any correlation between the number of days of DGF
and serum creatinine at either 3 or 12 months (p = 0.09 &
0.25 respectively).
There was a trend towards increased incidence of DGF
in those kidneys transplanted second although it did not
achieve statistical significance (p = 0.078). In addition, there
was no significant difference in any of the recipient factors
or short-term outcomes in terms of 3 and 12 month serum
creatinine between the two groups (Table 2).
However when we analysed paired kidneys with CIT
difference ≥3 hours showed an increased incidence of
DGF in the kidneys transplanted second [p = 0.05, RR
1.82 (95% CI 1–3.32)]. The difference in DGF between
first and second kidneys was further increased when the
difference in CIT was >4 hours [p = 0.01, RR 2.6 (95% CI
1.3-5.3)]. In this cohort, despite the significantly higher
peritoneal dialysis (PD) rate among the first kidney
transplant group (p = 0.006), the mode of dialysis (PD vs.
Haemodialysis) did not influence the incidence of DGF
(p = 0.64). However DGF was lower in patients who were
pre-emptive versus those being on either mode of dialy-
sis (p = 0.016, RR 13.2, 95% CI 1.6-107.7). These patients
were equally distributed between first and second kidney
groups (Table 2). The order of implantation continued
to significantly influence the incidence of DGF after con-
trolling for pretransplant dialysis (Table 4). Pre trans-
plant dialysis did not influence the incidence of DGF in
this cohort (p = 0.06).
Discussion
This study reviews the outcome of a local allocation policy
for DCD kidneys and the consequent impacts on CIT and
graft function. In the Pan Thames region both kidneys
from individual DCD donors have been primarily allo-
cated to one of 5 centres on a rota basis. With this mech-
anism of allocation and utilization there was a substantial
effect on CIT disadvantaging the second kidney from
Table 2 Differences between the first and second kidneys transplanted
Same centre transplant 2 centre transplant Total transplants
Kidney 1st Kidney 2nd p-value Kidney 1st Kidney 2nd p-value Kidney 1st Kidney 2nd p-value
n = 115(%) n = 115(%) n = 14(%) n = 14(%) n = 129(%) n = 129(%)
Recipient gender Male 78(68) 77(67) 8(57) 8(57) 86(67) 85(66)
Female 37(32) 38(33) 6(43) 6(43) 43(33) 44(34)
Dialysis Pre- 6(5) 4(3) 2(14) 3(21.5) 8(6) 7(5)
PD 44(38) 25(22) 0.0004 6(43) 3(21.5) 50(39) 28(22) 0.007
HD 65(57) 86(75) 6(43) 8(57) 71(55) 94(73)
Recipient HTN Yes 48(42) 45(39) 2(14) 8(57) 0.046 50(39) 53(41)
No 67(58) 70(61) 12(86) 6(43) 79(61) 76(59)
Recipient Diabetes Yes 18(16) 10(9) 2(14) 3(22) 20(16) 13(10)
No 97(84) 105(91) 12(86) 11(78) 109(84) 116(90)
Recipient IHD Yes 11(10) 6(5) 1(7) 1(7) 12(9) 7(5)
No 104(90) 109(95) 13(93) 13(93) 117(91) 122(95)
DGF Yes 64(56) 77(67) 8(57) 7(50) 72(56) 84(65)
No 51(44) 38(33) 6(43) 7(50) 57(44) 45(35)
Recipient age (Years ± SD) 50.5 ± 12.6 49.3 ± 12.8 49.4 ± 14.8 48.7 ± 10.2 50.4 ± 12.8 49.2 ± 12.5
CIT (hours ± SD) 15.5 ± 4.1 20.5 ± 5.8 <0.0001 15.8 ± 5.3 25.2 ± 5.5 0.0008 15.5 ± 4.2 20.9 ± 5.9 <0.0001
Sec. warm ischaemia time (min ± SD) 38.0 ± 13.8 (n = 85) 34.1 ± 11.8 (n = 85) 0.047 40.5 ± 7.4 34.5 ± 12.7
Creatinine at 3 mths (umols/L ± SD) 186.6 ± 173.1 177.7 ± 125.1 140.4 ± 49.4 141.6 ± 45.4 181.8 ± 165.2 170.7 ± 123.1
Creatinine at 12 months (umols/L ± SD) 168.8 ± 155.7 169.6 ± 173.4 122.5 ± 24.2 136.4 ± 43.5 164.1 ± 148.3 165.7 ± 163.9



















Table 3 Cold ischemia times of DCD kidney pairs
transplanted at single/multiple centres
Kidney 1 Kidney 2 p-value
Single centre Mean (hrs ± SD) 15.5 ± 4.1 20.5 ± 5.8 <0.0001
Median [hrs(IQR)] 15( 5.2) 19.25( 5.9)
Two centres Mean (hrs ± SD) 15.8 ± 5.3 25.2 ± 5.5 0.0008
Median [hrs(IQR)] 16.5( 8.6) 24(5.5)
Total Mean (hrs ± SD) 15.5 ± 4.2 20.9 ± 5.9 <0.0001
Median [hrs(IQR)] 15.3( 5.5) 19.5( 6.3)
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transplanted sequentially.
When both kidneys were used at a single centre, which
occurred in 90% of cases, the mean difference in CIT be-
tween the first and second implants approached 5 hours.
This is highly likely to reflect logistic issues related to
theatre and team constraints. Fixed delays contributing to
CIT including transport of organs and blood, cross match-
ing and patient preparation generally would equally apply
to both recipients. National UK data has demonstrated an
adverse effect of CIT on DGF and outcome when this
exceeds 12 hours [10]. Based on our experience in the
Pan Thames region, this target was generally not met
with current clinical practice even with the first of most
pairs of kidneys. Whilst various strategies, including virtual
cross matching, have been introduced to reduce CIT, re-
source limitations at individual units mostly restrict achiev-
ing this target for both kidneys from a single donor. The
present allocation policy thus inherently compromises a
substantial number of recipients of DCD kidneys.
An important observation is that where simultaneous
transplantation of both organs was achieved, based on
differences in CIT of <3 hours, the incidence of DGF
was identical with both kidneys. This scenario, however,
was only achieved in 20% of cases. With differences be-
yond 3 hours, which occurred in the majority of cases,
there was a negative effect on DGF with increasing time
to transplantation in the second kidney. This is consist-
ent with previous publications [4].
Patients on dialysis are known to be at increased risk of
DGF following cadaveric renal transplantation as compared
to those undergoing pre-emptive transplantation. Addition-
ally, the type of dialysis might also influence DGF in suchTable 4 Difference in DGF between the first and second kidne
differences in CIT
Difference in CIT Incidence of DGF
1st kidney 2nd kidney
<3 hours 67% (16/24) 67% (16/24)
≥3 hours 53% (48/91) 67% (61/91)
≥4 hours 48% (31/64) 70% (45/64)patients [13]. In our study we observed a significant differ-
ence in the mode of dialysis between first and second graft
recipients (Table 2). In single centre transplants there were
a higher proportion of patients undergoing peritoneal dialy-
sis in the recipients of the first kidney compared to the sec-
ond kidney. Although there was no difference in rates of
DGF between the different modalities of dialysis, there was
a significant difference in the rate of DGF between patients
on dialysis and those having pre-emptive transplants.
Multiple logistic regression confirmed that CIT difference
of ≥ 3 hours continued to remain an independent risk fac-
tor for DGF irrespective of pre-transplant dialysis status.
One potential mechanism to minimize the CIT of the
second kidney from a DCD donor would be the allocation
to 2 separate institutions. This only occurred in a minority
of cases and again generally resulted in sequential trans-
plantation. Unfortunately of great concern was the finding
that paradoxically this had an even greater adverse effect
on the CIT of the second kidney. Examining individual
cases this reflected the initial acceptance of both kidneys
by one institution followed by a secondary allocation oc-
curring when the first centre was unable to proceed with
both transplants. Various factors contributed to this, in-
cluding positive crossmatch and recipient medical unsuit-
ability without the ready availability of additional suitable
recipients, as well as technical concerns regarding one of
the kidneys by the surgical team at the initial centre. As a
consequence of this process which required subsequent re-
cipient identification, organ transport and cross matching
very substantial delays occur evidenced by the prolonged
CIT of approximately 10 hours for the second kidney.
The secondary WIT was found to be significantly lower
for the kidney transplanted second at the same centre.
However the time difference noted is unlikely to be of
clinical consequence and would not obviously account for
any of the outcomes noted.
Organ allocation from deceased donors can be both
controversial and dictated by local and regional factors
including resources as well as the recipient population.
This is compounded by the shortage of organs relative
to the number of patients who would benefit from renal
transplantation. There is substantial variation between and
within individual countries. Algorithms guiding alloca-
tion need to incorporate equity of access for potentialys transplanted at the same centre- subgroups based on
Odds ratio (95% CI) Odds ratio (95% CI)
Controlled for pre-transplant dialysis
NS -
1.8 (1–3.32) p = 0.05 1.9 (1–3.5) p = 0.046
2.6 (1.3-5.3) p = 0.01 2.7 (1.3-5.6) p = 0.009
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sible outcomes.
Health care costs vary between institutions and from
country to country. The current system in the London
region in the UK may address equity of organ allocation,
although we have not specifically examined this. It, how-
ever, does not ensure the optimal outcomes for all kidneys
based on this paired study. Infrastructure limitations within
transplant centres that prevent simultaneous transplant-
ation of both organs may compromise optimal outcomes.
The current accommodation cost for one day in our renal
transplant ward is £207 ($326) and our median length of
in-patient stay for renal transplants with DGF is 12 days,
significantly greater than 6 days for those transplants with
primary function. Thus DGF adds a minimum additional
£1242 ($1956) to the cost of the transplant just for
the increased hospital bed stay. However this excludes
the cost of medicines (immunosuppressants), additional
blood tests and other investigations, including renal trans-
plant biopsy, as our standard practice is to biopsy all
transplants with DGF at day 7.
We propose that kidneys from DCD donors should be
allocated through a mechanism to maximize the possibil-
ity of simultaneous transplantation to ensure prolongation
of the CIT of the second kidney does not occur. This
should be considered on a regional rather than national
level to minimize overall CIT.
We would recommend that for renal transplantation
using DCD allografts that if both kidneys are sent to the
same centre two contemporaneous transplants in separate
operating theatres should be performed to minimize the
risk of DGF and longer term renal injury [14]. In our opin-
ion, allocation of kidneys from each DCD donor should
be to 2 institutions within close geographical proximity.
Whilst some institutions may at times be able to ac-
commodate 2 transplants simultaneously, our study sug-
gests that in practice this is generally unlikely in most
transplant centres. Institutions accepting these kidneys
should ensure a backup recipient is available to avoid the
current practice of a secondary allocation process, which
has been shown to result in a profound and unaccept-
able delay in the majority of cases in which this occured.
A workable arrangement incorporating these require-
ments may be close cooperation between collaborating
units to provide a functional alternative to the current
arrangement.
A pilot collaboration programme has been established
between 2 transplant centres (Royal Free & Royal London
Hospitals) where they share the 2 kidneys from a single
DCD donor if offered to one of the two units. This has
helped to minimize most of the practical and logistical
problems of performing simultaneous transplants in the
same center hence with a shorter CIT. Given the initial
promising positive results of this shared acceptance systemof 2 kidneys, then it could be applied to other neighbouring
transplant units in greater London.
As a method of increasing the organ utilization we have
expanded the acceptance criteria for marginal donors, so
that in our region we transplant two marginal DCD kid-
neys into a single recipient (dual renal transplant). The
early outcomes data showed that transplanting two mar-
ginal kidneys, otherwise destined to be discarded is an ap-
propriate option for selected recipients. However if we
were to offer dual transplantation of all DCD kidneys,
then this would halve the number of potential recipients.Conclusion
The current primary allocation of both kidneys from a
DCD donor to single institutions within a UK transplant
region exposes the second kidney of the majority of pairs
to a significantly higher CIT and consequent risk of DGF.
Based on our experience, sequential transplantation re-
sults in unacceptable CIT for the second kidney trans-
planted from a DCD donor. Hence, it would be advisable
to share the paired kidneys based on a regional system in-
volving units in close proximity or if offered to the same
centre, ensure logistical support for simultaneous trans-
plantation. Additionally, following initial acceptance by a
centre, secondary re-allocation leads to an unacceptable
prolongation of CIT in the majority of cases. Where pos-
sible this should be avoided with back up patients avail-
able to ensure that the unsuitability of the initial planned
recipient does not adversely affect the CIT of the kidney.
We would also recommend other regions with similar
allocation protocols (i.e. both organs from a DCD donor
allocated to the same centre) review their performance
and outcomes, particularly with respect to the second
kidney of each pair. It is likely that the issues and out-
comes we have highlighted are widespread. This may lead
to a formal review of DCD kidney allocation across the
UK and other countries to improve the overall outcomes
from DCD donor kidney transplants.
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